GLUCOSAMINE MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS 2020 - 2027
Overview of the Market
Over the forecast period, the Global Glucosamine Market is expected to grow at a CAGR of 3.8 percent (2020-2027). Glucosamine is a popular supplement for treating osteoarthritis in the knees.
In the United States, glucosamine is classified as a dietary supplement. In Europe, however, it is a prescribed medication. Increased sedentary lifestyles among the general population in these areas are increasing the incidence of bone and joint problems, boosting the demand for bone and joint supplements like glucosamine.
Collagen peptides, hyaluronic acid, vitamins, and traditional medicines are some of the other components that are being used in conjunction with glucosamine. Glucosamine is predicted to grow in popularity as customers become more health conscious throughout the forecast period.
Market Trends to Watch
Supplements for Bone and Joint Health are being used more frequently.
According to the World Health Organization (WHO), osteoporosis will affect about 22 million people in Europe and 14 million in the United States alone. In 2017, it was estimated that over 200 million people were affected by osteoporosis. Bone and Joint Health Supplements are aimed for the ageing population, which is particularly prevalent in places such as North America and Europe, where the percentage of people over 65 is substantially higher. Maintaining a healthy lifestyle and preventing age-related bone disorders, especially in older people, is driving up the price of these supplements, as they provide health advantages while treating a specific segment of the human body.
Europe is the global Glucosamine Market leader.
Several variables in Europe are favourable to the expansion of the glucosamine industry. The number of people living with osteoarthritis is highest in this region. According to the World Health Organization (WHO), between 10% and 15% of people aged 60 and over suffer from osteoarthritis. Furthermore, the general public is well-informed about health and wellness supplements, particularly those for bone and joint health. These factors are significantly influencing the glucosamine industry in the region.
In the United States, glucosamine is classified as a dietary supplement. In Europe, however, it is a prescribed medication. Increased sedentary lifestyles among the general population in these areas are increasing the incidence of bone and joint problems, boosting the demand for bone and joint supplements like glucosamine.
Collagen peptides, hyaluronic acid, vitamins, and traditional medicines are some of the other components that are being used in conjunction with glucosamine. Glucosamine is predicted to grow in popularity as customers become more health conscious throughout the forecast period.
Market Trends to Watch
Supplements for Bone and Joint Health are being used more frequently.
According to the World Health Organization (WHO), osteoporosis will affect about 22 million people in Europe and 14 million in the United States alone. In 2017, it was estimated that over 200 million people were affected by osteoporosis. Bone and Joint Health Supplements are aimed for the ageing population, which is particularly prevalent in places such as North America and Europe, where the percentage of people over 65 is substantially higher. Maintaining a healthy lifestyle and preventing age-related bone disorders, especially in older people, is driving up the price of these supplements, as they provide health advantages while treating a specific segment of the human body.
Europe is the global Glucosamine Market leader.
Several variables in Europe are favourable to the expansion of the glucosamine industry. The number of people living with osteoarthritis is highest in this region. According to the World Health Organization (WHO), between 10% and 15% of people aged 60 and over suffer from osteoarthritis. Furthermore, the general public is well-informed about health and wellness supplements, particularly those for bone and joint health. These factors are significantly influencing the glucosamine industry in the region.
Comments
Post a Comment